Next, through K-M plotter analysis, we observed that low expression of RNF182 was associated with poor survival in LUAD patients (logrank P=4.3e-05) and lung cancer patients (logrank P=3.6e-07) (Figures 2D, E). Here, RNF182 is linked to lung cancer.